CoChat

Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

Abstract

Estrogens play a crucial physiological function in the brain; however, debates exist concerning the role of estrogens in Alzheimer's disease (AD). Women during pre-, peri-, or menopause periods are more susceptible for developing AD, suggesting the connection of sex factors and a decreased estrogen signaling in AD pathogenesis. Yet, the underlying mechanism of estrogen-mediated neuroprotection is unclarified and is complicated by the existence of estrogen-related factors. Consequently, a deeper analysis of estrogen receptor (ER) expression and estrogen-metabolizing enzymes could interpret the importance of estrogen in age-linked cognitive alterations. Previous studies propose that hormone replacement therapy may attenuate AD onset in postmenopausal women, demonstrating that estrogen signaling is important for the development and progression of AD. For example, ERα exerts neuroprotection against AD by maintaining intracellular signaling cascades and study reported reduced expression of ERα in hippocampal neurons of AD patients. Similarly, reduced expression of ERβ in female AD patients has been associated with abnormal function in mitochondria and improved markers of oxidative stress. In this review, we discuss the critical interaction between estrogen signaling and AD. Moreover, we highlight the potential of targeting estrogen-related signaling for therapeutic intervention in AD.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-020-01911-8

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 187 references

Research works printed but not linked: 1

  1. Garre-Olmo J (2018) Epidemiology of Alzheimer’s disease and other dementias. Rev Neurol 66:377–386

Cited by

See all 179

Metadata

Authors
Uddin, M. S., Rahman, M. M., Jakaria, M., Rahman, M. S., Hossain, M. S., Islam, A., Ahmed, M., Mathew, B., Omar, U. M., Barreto, G. E., & Ashraf, G. M.
Affiliations
  • Southeast University (BD)
  • University of Toyama (JP)
  • The University of Melbourne (AU)
  • Università di Camerino (IT)
  • Rowan University (US)
  • Daffodil International University (BD)
  • King Abdulaziz University (SA)
  • University of Limerick (IE)
Corresponding author
  • Uddin, Md. Sahab
  • Barreto, George E.
  • Ashraf, Ghulam Md
Venue
Molecular Neurobiology
Published
2020-04-15
Volume
57
Issue
6
Pages
2654-2670
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W3016510909
Cited by
156
References
186
Citations by year
2026: 17 · 2025: 27 · 2024: 29 · 2023: 26 · 2022: 15 · 2021: 27 · 2020: 15
FWCI
2.96
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
estrogen signaling, Alzheimer's disease, estrogen receptor, estrogen receptor alpha, estrogen receptor beta, hormone replacement therapy, menopause, sex differences, neuroprotection, oxidative stress, mitochondrial dysfunction, hippocampal neurons, therapeutic target
MeSH terms
Alzheimer Disease, Brain, Estrogens, Humans, Neurons, Receptors, Estrogen, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia. https://app.cochat.ai/papers/10.1007/s12035-020-01911-8
The paper
Uddin, M. S., Rahman, M. M., Jakaria, M., Rahman, M. S., Hossain, M. S., Islam, A., Ahmed, M., Mathew, B., Omar, U. M., Barreto, G. E., & Ashraf, G. M. (2020). Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia. Molecular Neurobiology. https://doi.org/10.1007/s12035-020-01911-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.